Joseph Oriti
Chief Accounting Officer
Sagimet Biosciences Inc. (SGMT)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Joseph Oriti
Joseph Oriti is recorded as CFO and Chief Accounting Officer at Sagimet Biosciences Inc. (SGMT). Sagimet Biosciences Inc. reported in an 8-K filed February 2, 2024 that Joseph Oriti was appointed Interim Principal Accounting Officer, effective February 1, 2024. Sagimet Biosciences Inc. reported in an 8-K filed February 2, 2024 that Joseph Oriti was appointed Interim Principal Financial Officer, effective February 1, 2024.
“On January 31, 2024, the board of directors (the "Board") of the Company appointed Joseph Oriti as Interim Principal Financial Officer and Interim Principal Accounting Officer, effective as of February 1, 2024 (the "Effective Date").”
“On January 31, 2024, the board of directors (the "Board") of the Company appointed Joseph Oriti as Interim Principal Financial Officer and Interim Principal Accounting Officer, effective as of February 1, 2024 (the "Effective Date").”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2024-02-01–present
-
Current
2024-02-01–present
-
Sagimet Biosciences Inc. (SGMT)
Proxy statement
Start not stated–2024-04-18
Last confirmed by a filing; no departure on record
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Sagimet Biosciences Inc.
Other people whose current roles at this company are on record from its filings.
- David Happel CEO, Board Member
- George Kemble Chairman, Board Member
- Anthony Rimac CFO, Chief Accounting Officer
- Dennis Hom CFO
- Thierry Chauche CFO
- Elizabeth Rozek General Counsel
- Anne Phillips Board Member
- Beth Seidenberg, M.D. Board Member
- Jennifer Jarrett Board Member
- Tim Walbert Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.